Title : Dual, HLA-B27 subtype-dependent conformation of a self-peptide.

Pub. Date : 2004 Jan 19

PMID : 14734527






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The products of the human leukocyte antigen subtypes HLA-B*2705 and HLA-B*2709 differ only in residue 116 (Asp vs. His) within the peptide binding groove but are differentially associated with the autoimmune disease ankylosing spondylitis (AS); HLA-B*2705 occurs in AS-patients, whereas HLA-B*2709 does not. Aspartic Acid major histocompatibility complex, class I, B Homo sapiens
2 The products of the human leukocyte antigen subtypes HLA-B*2705 and HLA-B*2709 differ only in residue 116 (Asp vs. His) within the peptide binding groove but are differentially associated with the autoimmune disease ankylosing spondylitis (AS); HLA-B*2705 occurs in AS-patients, whereas HLA-B*2709 does not. Aspartic Acid major histocompatibility complex, class I, B Homo sapiens
3 The products of the human leukocyte antigen subtypes HLA-B*2705 and HLA-B*2709 differ only in residue 116 (Asp vs. His) within the peptide binding groove but are differentially associated with the autoimmune disease ankylosing spondylitis (AS); HLA-B*2705 occurs in AS-patients, whereas HLA-B*2709 does not. Aspartic Acid major histocompatibility complex, class I, B Homo sapiens
4 The products of the human leukocyte antigen subtypes HLA-B*2705 and HLA-B*2709 differ only in residue 116 (Asp vs. His) within the peptide binding groove but are differentially associated with the autoimmune disease ankylosing spondylitis (AS); HLA-B*2705 occurs in AS-patients, whereas HLA-B*2709 does not. Aspartic Acid major histocompatibility complex, class I, B Homo sapiens